Compare TOI & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TOI | JFIN |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | China |
| Employees | 641 | N/A |
| Industry | Medical/Nursing Services | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.4M | 247.1M |
| IPO Year | N/A | 2018 |
| Metric | TOI | JFIN |
|---|---|---|
| Price | $3.34 | $4.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $6.67 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 79.8K |
| Earning Date | 05-13-2026 | 06-03-2026 |
| Dividend Yield | N/A | ★ 17.17% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $30.15 | N/A |
| Revenue Next Year | $25.77 | N/A |
| P/E Ratio | ★ N/A | $1.35 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.02 | $3.70 |
| 52 Week High | $4.88 | $18.70 |
| Indicator | TOI | JFIN |
|---|---|---|
| Relative Strength Index (RSI) | 53.72 | 42.94 |
| Support Level | $2.96 | $3.70 |
| Resistance Level | $3.74 | $5.00 |
| Average True Range (ATR) | 0.19 | 0.23 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 52.04 | 52.98 |
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital plus technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.